Citalopram-induced severe hyponatraemia with coma and seizure. Case report with literature and spontaneous reports review.

Alexander Fisher, Michael Davis, James Croft-Baker, Patrick Purcell, Allan McLean
{"title":"Citalopram-induced severe hyponatraemia with coma and seizure. Case report with literature and spontaneous reports review.","authors":"Alexander Fisher,&nbsp;Michael Davis,&nbsp;James Croft-Baker,&nbsp;Patrick Purcell,&nbsp;Allan McLean","doi":"10.1007/BF03256195","DOIUrl":null,"url":null,"abstract":"<p><p>Numerous case reports of hyponatraemia followed increasing use of selective serotonin re-uptake inhibitors (SSRIs) but this adverse effect was only rarely observed in relation to citalopram. We report a case of severe hyponatraemia associated with deep coma, seizure, atrial fibrillation and muscle damage in a 92-year-old woman after only two doses of citalopram, and review 14 cases previously published in the literature and 28 cases spontaneously reported to Australian Drug Reaction Advisory Committee (ADRAC). The data presented suggest that citalopram, as well as SSRIs may cause hyponatraemia secondary to syndrome of inappropriate secretion of antidiuretic hormone (SIADH). The majority of symptomatic cases occurred in elderly patients (79% were older than 70 years) and in women (74%). Polymedication and concomitant use of another psychotropic drug or thiazide diuretic may precipitate and/or augment the development of hyponatraemia/SIADH. In 84% of cases, the hyponatraemia associated with citalopram was detected during the first month of treatment. High level of suspicion, close and careful monitoring of serum sodium concentration particularly in elderly patients and especially in the first month of therapy with citalopram may reduce the incidence of this serious and likely not rare adverse effect.</p>","PeriodicalId":7401,"journal":{"name":"Adverse drug reactions and toxicological reviews","volume":"21 4","pages":"179-87"},"PeriodicalIF":0.0000,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03256195","citationCount":"30","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Adverse drug reactions and toxicological reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03256195","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 30

Abstract

Numerous case reports of hyponatraemia followed increasing use of selective serotonin re-uptake inhibitors (SSRIs) but this adverse effect was only rarely observed in relation to citalopram. We report a case of severe hyponatraemia associated with deep coma, seizure, atrial fibrillation and muscle damage in a 92-year-old woman after only two doses of citalopram, and review 14 cases previously published in the literature and 28 cases spontaneously reported to Australian Drug Reaction Advisory Committee (ADRAC). The data presented suggest that citalopram, as well as SSRIs may cause hyponatraemia secondary to syndrome of inappropriate secretion of antidiuretic hormone (SIADH). The majority of symptomatic cases occurred in elderly patients (79% were older than 70 years) and in women (74%). Polymedication and concomitant use of another psychotropic drug or thiazide diuretic may precipitate and/or augment the development of hyponatraemia/SIADH. In 84% of cases, the hyponatraemia associated with citalopram was detected during the first month of treatment. High level of suspicion, close and careful monitoring of serum sodium concentration particularly in elderly patients and especially in the first month of therapy with citalopram may reduce the incidence of this serious and likely not rare adverse effect.

西酞普兰引起的严重低钠血症伴昏迷和癫痫发作。病例报告,文献和自发报告复习。
选择性5 -羟色胺再摄取抑制剂(SSRIs)的使用增加后出现了大量低钠血症病例报告,但这种副作用在西酞普兰中很少观察到。我们报告了一名92岁女性在服用两剂西酞普兰后出现严重低钠血症并伴有深度昏迷、癫痫发作、心房颤动和肌肉损伤的病例,并回顾了先前发表的14例文献和28例自发报告给澳大利亚药物反应咨询委员会(ADRAC)的病例。数据提示西酞普兰和SSRIs可能引起继发于抗利尿激素分泌不当综合征(SIADH)的低钠血症。大多数有症状的病例发生在老年患者(79%年龄大于70岁)和女性(74%)。多种药物治疗和同时使用其他精神药物或噻嗪类利尿剂可促进和/或增加低钠血症/SIADH的发展。在84%的病例中,在治疗的第一个月检测到与西酞普兰相关的低钠血症。高度怀疑,密切和仔细监测血清钠浓度,特别是在老年患者,特别是在西酞普兰治疗的第一个月,可以减少这种严重的,可能并不罕见的不良反应的发生率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信